Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126165303 | 12616530 | 3 | F | 20160803 | 20160802 | 20160816 | EXP | US-CELGENEUS-USA-2016077067 | CELGENE | 0.00 | M | Y | 85.20000 | KG | 20160816 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126165303 | 12616530 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | 20785 | 200 | MG | CAPSULES | ||||||
126165303 | 12616530 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | U | 20785 | 200 | MG | CAPSULES | ||||||
126165303 | 12616530 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 10 | MG | CAPSULES | QD | |||||
126165303 | 12616530 | 4 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
126165303 | 12616530 | 5 | C | Multivitamin | VITAMINS | 1 | Unknown | 0 | UNKNOWN | ||||||||||
126165303 | 12616530 | 6 | C | ULTRACET | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126165303 | 12616530 | 1 | Plasma cell myeloma |
126165303 | 12616530 | 3 | Plasma cell myeloma |
126165303 | 12616530 | 4 | Product used for unknown indication |
126165303 | 12616530 | 5 | Product used for unknown indication |
126165303 | 12616530 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126165303 | 12616530 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126165303 | 12616530 | Blood creatinine increased | |
126165303 | 12616530 | Haemoglobin decreased | |
126165303 | 12616530 | Neuropathy peripheral | |
126165303 | 12616530 | Plasma cell myeloma | |
126165303 | 12616530 | Platelet count decreased | |
126165303 | 12616530 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126165303 | 12616530 | 1 | 201601 | 20160628 | 0 | |
126165303 | 12616530 | 2 | 20160727 | 0 | ||
126165303 | 12616530 | 3 | 20160712 | 20160726 | 0 |